Zarcone

Canary RX Announces Year to Date Wholesale Cannabis Sales

Retrieved on: 
Tuesday, October 5, 2021
The Company, Securities Act of 1933, OTCQB, Security (finance), Drug Quality and Security Act, U.S. Securities and Exchange Commission, Multimedia, Cannabis Act, CEO, Zarcone, Acquisition, Company, Terminology, Growth, Health Canada, Canary, Audience, Contract, Forward-looking statement, Securities Exchange Act of 1934, Retail, Online shopping

These year-to-date sales have been established through multiple wholesale and brand partners across the country facilitated through our Joint Venture operation, Venn Cannabis.

Key Points: 
  • These year-to-date sales have been established through multiple wholesale and brand partners across the country facilitated through our Joint Venture operation, Venn Cannabis.
  • Canary flower has all the attributes required of premium craft flower to maintain anticipated price thresholds in a challenging marketplace.
  • Canary Rx Inc. ("Canary") isa Licensed Producerunder the Cannabis Act.
  • The Company owns and operates Canary RX Inc, a Health Canada licensed producer under The Cannabis Act (Bill C-45), and CannaKorp, makers of the pod-based Wisp Vapor technology.

Canary RX Receives its Health Canada Sales License

Retrieved on: 
Wednesday, September 15, 2021
U.S. Securities and Exchange Commission, Security (finance), Certification, CEO, OTCQB, Forward-looking statement, Zarcone, Audience, Securities Exchange Act of 1934, Cannabis Act, Company, Drug Quality and Security Act, CPG, VENN, Terminology, Growth, Multimedia, Partnership, Canary, Health Canada, Securities Act of 1933, The Company, Acquisition, News, Drug

NORFOLK COUNTY, ON, Sept. 15, 2021 /PRNewswire/ - Target Group Inc. (OTCQB: CBDY)is pleased to announce that its wholly owned subsidiary, Canary Rx Inc. ("Canary" or the "Company") has received its Health Canada sales license.

Key Points: 
  • NORFOLK COUNTY, ON, Sept. 15, 2021 /PRNewswire/ - Target Group Inc. (OTCQB: CBDY)is pleased to announce that its wholly owned subsidiary, Canary Rx Inc. ("Canary" or the "Company") has received its Health Canada sales license.
  • Canary RX, through its joint venture partnership, Venn Cannabis, has been working meticulously to ensure production of ultra-premium, craft cannabis in its Simcoe, Ontario production facility.
  • Receiving the sales license at our Simcoe, Ontario facility is tremendously positive news for Canary RX and VENN, our joint-venture with Thrive Cannabis," saidTony Zarcone, CEO of Target Group & Canary RX Inc.
    Canary Rx Inc. ("Canary") isa Licensed Producerunder the Cannabis Act.
  • The Company owns and operates Canary RX Inc, a Health Canada licensed producer under The Cannabis Act (Bill C-45), and CannaKorp, makers of the pod-based Wisp Vapor technology.

LKQ Corporation Completes Divestiture of AeroVision International

Retrieved on: 
Monday, August 19, 2019
LKQ Corporation, Economy of the United States, Zarcone, NASDAQ, GlobeNewswire, Finance

CHICAGO, Aug. 19, 2019 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) today announced it has divested its recycled aviation parts business, AeroVision International, effective August 18, 2019.

Key Points: 
  • CHICAGO, Aug. 19, 2019 (GLOBE NEWSWIRE) -- LKQ Corporation (Nasdaq: LKQ) today announced it has divested its recycled aviation parts business, AeroVision International, effective August 18, 2019.
  • Dominick Zarcone, President and Chief Executive Officer of LKQ Corporation, stated, "The evaluation and rationalization of our asset base is a core strategic pillar for our Company.
  • As part of this ongoing process, and after thorough consideration, we determined that AeroVision didnt align with our long-term strategy and objectives.
  • LKQ Corporation( www.lkqcorp.com ) is a leading provider of alternative and specialty parts to repair and accessorize automobiles and other vehicles.